US4547461A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition, analytical element and method for the quantification of creatine kinase
Assignee: Clinical Diagnostic Systems Inc
•
Filing: 1983-01-18
•
Granted: 1985-10-15
•
Expires: 2003-01-18
Abstract
Abstract An enzymatic method for the analytical determination of creatine kinase in an aqueous liquid such as blood serum is described. The determination is made by measuring an optical density change using the reagents creatine phosphate, adenosine diphosphate, glycerol, glycerol kinase, alpha -glycerophosphate oxidase, a chromagen and a mercapto-containing creatine kinase activator. The mercapto-containing creatine kinase activator is added in encapsulated form or in low concentrations so as to preserve the activity of the chromagen.
Inventors
- 👤 Theodore W. Esders
- 👤 Shirley Y. Lynn
- 👤 John B. Findlay
- 👤 Richard M. Schubert
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 13:59
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/48; C12Q1/26; C12Q1/28; C12Q1/50; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/81
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
65 words
A composition for the quantification of creatine kinase in an aqueous liquid, said composition comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising a chromogen; and (g) a mercapto-containing creatine kinase activator which is present in encapsulated form or at a concentration such that it will not interfere with said colorimetric indicator composition.
Claim 2
Dependent Claim
65 words
A composition for the quantification of creatine kinase in an aqueous liquid, said composition comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising a chromogen; and (g) a mercapto-containing creatine kinase activator which is present in encapsulated form or at a concentration such that it will not interfere with said colorimetric indicator composition.
Claim 3
Dependent Claim
16 words
The composition of claim 1 wherein said colorimetric indicator composition comprises a substance having peroxidative activity.
Claim 4
Dependent Claim
11 words
The composition of claim 2 wherein said peroxidative substance is peroxidase.
Claim 5
Dependent Claim
27 words
The composition of claim 2 wherein said chromogen is a material capable of undergoing a colorimetric change in the presence of a peroxide and said peroxidative substance.
Claim 6
Dependent Claim
12 words
The composition of claim 1 wherein said chromogen is a dye-forming substance.
Claim 7
Dependent Claim
12 words
The composition of claim 5 wherein said chromogen is a leuco dye.
Claim 8
Dependent Claim
35 words
The composition of claim 1 which is useful in a solution assay for creatine kinase wherein said creatine kinase activator is present in an amount less than about 0.2 mM based on final assay volume.
Claim 9
Dependent Claim
11 words
The composition of claim 1 wherein said mercapto-containing compound is N-acetylcysteine.
Claim 10
Dependent Claim
9 words
The composition of claim 1 containing an electron acceptor.
Claim 11
Dependent Claim
53 words
An analytical element for detecting creatine kinase, said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a chromogen; and a mercapto-containing creatine kinase activator which is present in encapsulated form or in a location such that it does not interfere with said colorimetric indicator composition.
Claim 12
Dependent Claim
53 words
An analytical element for detecting creatine kinase, said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a chromogen; and a mercapto-containing creatine kinase activator which is present in encapsulated form or in a location such that it does not interfere with said colorimetric indicator composition.
Claim 13
Dependent Claim
63 words
An analytical element for detecting creatine kinase, said element including a support and, in fluid contact, first and second zones; and said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a chromogen; and a mercapto-containing creatine kinase activator, said first zone containing said colorimetric indicator composition, and said second zone containing said creatine kinase activator.
Claim 14
Dependent Claim
63 words
An analytical element for detecting creatine kinase, said element including a support and, in fluid contact, first and second zones; and said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a chromogen; and a mercapto-containing creatine kinase activator, said first zone containing said colorimetric indicator composition, and said second zone containing said creatine kinase activator.
Claim 15
Dependent Claim
16 words
The element of claim 11 wherein said colorimetric indicator composition comprises a substance having peroxidative activity.
Claim 16
Dependent Claim
27 words
The element of claim 12 wherein said chromogen is a material capable of undergoing a colorimetric change in the presence of a peroxide and said peroxidative substance.
Claim 17
Dependent Claim
11 words
The element of claim 13 wherein said peroxidative substance is peroxidase.
Claim 18
Dependent Claim
13 words
The element of claim 11 wherein said first zone is adjacent said support.
Claim 19
Dependent Claim
62 words
An analytical element for detecting creatine kinase, said element including a support and, in fluid contact, first and second zones; and said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a substance having peroxidative activity, and a chromogen; and N-acetylcysteine, said first zone containing said colorimetric indicator composition, and said second zone containing N-acetylcysteine.
Claim 20
Dependent Claim
62 words
An analytical element for detecting creatine kinase, said element including a support and, in fluid contact, first and second zones; and said element comprising: creatine phosphate; adenosine diphosphate; glycerol; glycerol kinase; α-glycerophosphate oxidase; a colorimetric indicator composition comprising a substance having peroxidative activity, and a chromogen; and N-acetylcysteine, said first zone containing said colorimetric indicator composition, and said second zone containing N-acetylcysteine.
Claim 21
Dependent Claim
25 words
The element of claim 16 wherein said N-acetylcysteine is present in said second zone at a coverage of up to about 2 g/m 2 .
Claim 22
Dependent Claim
86 words
An analytical element for detecting creatine kinase, said element including a support having thereon, in order from said support and in fluid contact with each other, a registration zone containing α-glycerophosphate oxidase and a colorimetric indicator composition comprising a substance having peroxidative activity, and a chromogen; a reagent zone containing creatine phosphate, adenosine diphosphate, glycerol and glycerol kinase; and an isotropically porous spreading zone containing a mercapto-containing creatine kinase activator wherein the zones are positioned in a manner such that one is superimposed on the other.
Claim 23
Dependent Claim
86 words
An analytical element for detecting creatine kinase, said element including a support having thereon, in order from said support and in fluid contact with each other, a registration zone containing α-glycerophosphate oxidase and a colorimetric indicator composition comprising a substance having peroxidative activity, and a chromogen; a reagent zone containing creatine phosphate, adenosine diphosphate, glycerol and glycerol kinase; and an isotropically porous spreading zone containing a mercapto-containing creatine kinase activator wherein the zones are positioned in a manner such that one is superimposed on the other.
Claim 24
Dependent Claim
27 words
The element of claim 18 wherein said colorimetric indicator composition comprises peroxidase and a leuco dye which is oxidized in the presence of hydrogen peroxide and peroxidase.
Claim 25
Independent Claim
139 words
A method for the quantification of creatine kinase in an aqueous liquid, said method comprising the steps of: (A) incubating a sample of said liquid in the presence of less than about 0.2 mM of a mercapto-containing creatine kinase activator to activate creatine kinase; (B) contacting (1) a sample of said activated liquid sample, and (2) reagents which effect in the presence of a creatine kinase-containing liquid, an ordered sequence of reactions wherein: (a) creatine phosphate and adenosine diphosphate react in the presence of creatine kinase to form creatine and adenosine triphosphate; (b) glycerol is phosphorylated in the presence of glycerol kinase and adenosine triphosphate to form L-α-glycerophosphate; and (c) L-α-glycerophosphate is oxidized in the presence of α-glycerophosphate oxidase and a colorimetric indicator composition to produce an optical density change; and (C) quantitatively detecting the rate of said change.
Claim 26
Independent Claim
139 words
A method for the quantification of creatine kinase in an aqueous liquid, said method comprising the steps of: (A) incubating a sample of said liquid in the presence of less than about 0.2 mM of a mercapto-containing creatine kinase activator to activate creatine kinase; (B) contacting (1) a sample of said activated liquid sample, and (2) reagents which effect in the presence of a creatine kinase-containing liquid, an ordered sequence of reactions wherein: (a) creatine phosphate and adenosine diphosphate react in the presence of creatine kinase to form creatine and adenosine triphosphate; (b) glycerol is phosphorylated in the presence of glycerol kinase and adenosine triphosphate to form L-α-glycerophosphate; and (c) L-α-glycerophosphate is oxidized in the presence of α-glycerophosphate oxidase and a colorimetric indicator composition to produce an optical density change; and (C) quantitatively detecting the rate of said change.
Claim 27
Independent Claim
109 words
A method for the quantification of creatine kinase in an aqueous liquid, said method comprising the steps of: (A) contacting in an aqueous medium and in the presence of an electron acceptor (1) a sample of said liquid, and (2) a reagent composition comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising a chromogen; and (g) a mercapto-containing creatine kinase activator which is present in encapsulated form or at a concentration such that it will not intefere with said colorimetric indicator composition, to produce an optical density change; and (B) quantitatively detecting the rate of said change.
Claim 28
Independent Claim
109 words
A method for the quantification of creatine kinase in an aqueous liquid, said method comprising the steps of: (A) contacting in an aqueous medium and in the presence of an electron acceptor (1) a sample of said liquid, and (2) a reagent composition comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising a chromogen; and (g) a mercapto-containing creatine kinase activator which is present in encapsulated form or at a concentration such that it will not intefere with said colorimetric indicator composition, to produce an optical density change; and (B) quantitatively detecting the rate of said change.
Claim 29
Dependent Claim
20 words
The method of claim 21 wherein said colorimetric indicator composition comprises a leuco dye and a substance having peroxidative activity.
Claim 30
Dependent Claim
12 words
The method of claim 21 wherein said creatine kinase activator is N-acetylcysteine.
Claim 31
Independent Claim
133 words
A method for the quantification of creatine kinase in blood serum, said method comprising the steps of: (A) contacting in an aqueous medium and in the presence of oxygen (1) a sample of said blood serum, and (2) a reagent composition buffered to a pH of between about 6 and about 9 and comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising peroxidase and a chromogen which provides quantifiable colorimetric change in the presence of hydrogen peroxide and peroxidase; and (g) a mercapto-containing activator for creatine kinase, which activator is present in an amount which renders said activator substantially inert to said colorimetric indicator composition, to produce a quantifiable colorimetric change; and (B) quantitatively detecting the rate of said colorimetric change.
Claim 32
Independent Claim
133 words
A method for the quantification of creatine kinase in blood serum, said method comprising the steps of: (A) contacting in an aqueous medium and in the presence of oxygen (1) a sample of said blood serum, and (2) a reagent composition buffered to a pH of between about 6 and about 9 and comprising: (a) creatine phosphate; (b) adenosine diphosphate; (c) glycerol; (d) glycerol kinase; (e) α-glycerophosphate oxidase; (f) a colorimetric indicator composition comprising peroxidase and a chromogen which provides quantifiable colorimetric change in the presence of hydrogen peroxide and peroxidase; and (g) a mercapto-containing activator for creatine kinase, which activator is present in an amount which renders said activator substantially inert to said colorimetric indicator composition, to produce a quantifiable colorimetric change; and (B) quantitatively detecting the rate of said colorimetric change.
Claim 33
Dependent Claim
28 words
The method of claim 24 wherein said mercapto-containing activator is N-acetylcysteine present in an amount of less than about 0.2 mM as measured in the final assay solution.
Claim 34
Independent Claim
114 words
A method for the quantification of creatine kinase in blood serum, said method comprising the steps of: (A) contacting, in the presence of oxygen, a sample of said blood serum and an analytical element, said element including a support and, in order from said support and in fluid contact with each other, a registration zone containing α-glycerophosphate oxidase, peroxidase and a leuco dye which is oxidized in the presence of hydrogen peroxide and peroxidase; a reagent zone containing creatine phosphate, adenosine diphosphate, glycerol and glycerol kinase; and an isotropically porous spreading zone containing a mercapto-containing creatine kinase activator, to produce a quantifiable colorimetric change; and (B) quantitatively detecting the rate of said colorimetric change.
Claim 35
Independent Claim
114 words
A method for the quantification of creatine kinase in blood serum, said method comprising the steps of: (A) contacting, in the presence of oxygen, a sample of said blood serum and an analytical element, said element including a support and, in order from said support and in fluid contact with each other, a registration zone containing α-glycerophosphate oxidase, peroxidase and a leuco dye which is oxidized in the presence of hydrogen peroxide and peroxidase; a reagent zone containing creatine phosphate, adenosine diphosphate, glycerol and glycerol kinase; and an isotropically porous spreading zone containing a mercapto-containing creatine kinase activator, to produce a quantifiable colorimetric change; and (B) quantitatively detecting the rate of said colorimetric change.
References Cited (Backward Citations)
US3992158A
Cited
US4012286A
Cited
US4089747A
Cited
US4118279A
Cited
US4166005A
Cited
US4241178A
Cited
US4352881A
Cited
US4286057A
Cited
EP0060518B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-10-14 | 1989-04-15 | 1989-10-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-10-14 | 1993-04-15 | 1993-10-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-10-14 | 1997-04-15 | 1997-10-15 | $7700.00 | Window Closed / Lapsed |